The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome

European Journal of Heart FailureVolume 25, Issue 1 p. 74-76 Invited Editorial The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome Giuseppe Boriani, Corresponding Author Giuseppe Boriani [email protected] Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy Corresponding author. Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, 41124 Modena, Italy. Email: [email protected]Search for more papers by this authorJacopo F. Imberti, Jacopo F. Imberti Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, ItalySearch for more papers by this authorMarco Vitolo, Marco Vitolo Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, ItalySearch for more papers by this author Giuseppe Boriani, Corresponding Author Giuseppe Boriani [email protected] Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy Corresponding author. Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, 41124 Modena, Italy. Email: [email protected]Search for more papers by this authorJacopo F. Imberti, Jacopo F. Imberti Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, ItalySearch for more papers by this authorMarco Vitolo, Marco Vitolo Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, ItalySearch for more papers by this author First published: 15 December 2022 https://doi.org/10.1002/ejhf.2755Citations: 1 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2729 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Boriani G, Vitolo M, Diemberger I, Proietti M, Valenti AC, Malavasi VL, et al. Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res. 2021; 117: 1–21. 2Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021; 23: 352–80. 3 Patel RB, Greene SJ, Xu H, Alhanti B, Peterson P, Yancy CW, et al. Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines-Heart Failure Registry. Eur J Heart Fail. 2023; 25: 63–73. 4Sgreccia D, Manicardi M, Malavasi VL, Vitolo M, Valenti AC, Proietti M, et al. Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients. J Clin Med. 2021; 10:3979. 5Boriani G, Palmisano P, Malavasi VL, Fantecchi E, Vitolo M, Bonini N, et al. Clinical factors associated with atrial fibrillation detection on single-time point screening using a hand-held single-lead ECG device. J Clin Med. 2021; 10:729. 6Svennberg E, Tjong F, Goette A, Akoum N, Di Biase L, Bordachar P, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022; 24: 979–1005. 7Boriani G, Maisano A, Bonini N, Albini A, Imberti JF, Venturelli A, et al. Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey. J Geriatr Cardiol. 2021; 18: 739–47. 8Salamanca-Bautista P, Álvarez-García J, Aramburu-Bodas Ó, Ferrero-Gregori A, Arias-Jiménez JL, Delgado JF, et al. Modes of death in heart failure according to age, sex and left ventricular ejection fraction. Intern Emerg Med. 2021; 16: 643–52. 9Marra AM, Bencivenga L, D'Assante R, Rengo G, Cittadini A. Heart failure with preserved ejection fraction: squaring the circle between comorbidities and cardiovascular abnormalities. Eur J Intern Med. 2022; 99: 1–6. 10Imberti JF, Mei DA, Vitolo M, Bonini N, Proietti M, Potpara T, et al. Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med. 2022; 101: 1–7. 11Romiti GF, Proietti M, Vitolo M, Bonini N, Fawzy AM, Ding WY, et al. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC Med. 2022; 20:326. 12Eckardt L, Sehner S, Suling A, Borof K, Breithardt G, Crijns H, et al. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial. Eur Heart J. 2022; 43: 4127–44. 13Boriani G, Vitolo M, Imberti JF. Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction. Eur J Heart Fail. 2022; 24: 1647–51. 14Boriani G, Imberti JF, Vitolo M. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? Eur J Heart Fail. 2022; 24: 1102–5. 15Tavazzi L, Maggioni AP, Rapezzi C, Ferrari R. Heart failure and catheter ablation of atrial fibrillation: navigating the difficult waters of heart failure phenotypes. Eur J Intern Med. 2022; 99: 13–8. 16von Olshausen G, Benson L, Dahlström U, Lund LH, Savarese G, Braunschweig F. Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry. Eur J Heart Fail. 2022; 24: 1636–46. 17Fujimoto H, Doi N, Okayama S, Naito M, Kobori A, Kaitani K, et al. Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction. Europace. 2022; 24: 576–86. 18Uijl A, Savarese G, Vaartjes I, Dahlström U, Brugts JJ, Linssen GCM, et al. Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction. Eur J Heart Fail. 2021; 23: 973–82. 19Casebeer A, Horter L, Hayden J, Simmons J, Evers T. Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization. J Cardiovasc Med (Hagerstown). 2021; 22: 45–52. 20Malavasi VL, Fantecchi E, Tordoni V, Melara L, Barbieri A, Vitolo M, et al. Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. Intern Emerg Med. 2021; 16: 1131–40. Citing Literature Volume25, Issue1January 2023Pages 74-76 ReferencesRelatedInformation